Clinical Trial

Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

Study acronym: DAPTLong
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of study is to evaluate the efficacy and safety of 1 year duration of DAPT after GENOSS® DES Implantation in patients with coronary artery disease according to the complex higher-risk (and indicated) procedure.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-04; most recent amendment 2025-02-18.
Trial Details
NCT Number NCT06075433
Lead Sponsor Genoss Co., Ltd.
Conditions Coronary Artery Disease, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy
Enrollment 1,000 participants
Start Date 2022-05-13
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-21